Contribution of decreased serotonin release to the antidyskinetic effects of deep brain stimulation in a rodent model of tardive dyskinesia: Comparison of the subthalamic and entopeduncular nuclei

Journal of Neuroscience

Volumn 32, Issue 28, 2012, Pages 9574-9581

  Creed, Meaghan C ^a   Hamani, Clement ^a   Bridgman, Alanna ^a   Fletcher, Paul J ^a   Nobrega, José N ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 4 IODO 2, 5 DIMETHOXYAMPHETAMINE; FENFLURAMINE; FLUOXETINE; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BEHAVIOR; BRAIN DEPTH STIMULATION; CAUDATE NUCLEUS; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; ENTOPEDUNCULAR NUCLEUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMEDIATE EARLY GENE; IN SITU HYBRIDIZATION; MALE; MASTICATION; MICRODIALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; SUBTHALAMIC NUCLEUS; TARDIVE DYSKINESIA;

5,7-DIHYDROXYTRYPTAMINE; AMPHETAMINES; ANALYSIS OF VARIANCE; ANIMALS; ANTIPSYCHOTIC AGENTS; AUTORADIOGRAPHY; BENZYLAMINES; CARBON ISOTOPES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEEP BRAIN STIMULATION; DISEASE MODELS, ANIMAL; ELECTROCHEMICAL TECHNIQUES; ENTOPEDUNCULAR NUCLEUS; EXPLORATORY BEHAVIOR; FLUOXETINE; HALOPERIDOL; HYDROXYINDOLEACETIC ACID; MALE; MASTICATION; MICRODIALYSIS; MOVEMENT DISORDERS; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGENTS; SEROTONIN RECEPTOR AGONISTS; SEROTONIN UPTAKE INHIBITORS; SUBTHALAMIC NUCLEUS;

EID: 84863638351     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1196-12.2012     Document Type: Article

References (45)

1. Alex KD, Pehek EA (2007) Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther 113:296-320.
2. Blier P, Steinberg S, Chaput Y, de Montigny C (1989) Electrophysiological assessment of putative antagonists of 5-hydroxytryptamine receptors: a single-cell study in the rat dorsal raphe nucleus. Can J Physiol Pharmacol 67:98-105.
3. Caley CF (1998) Extrapyramidal reactions from concurrent SSRI and atypical antipsychotic use. Can J Psychiatry 43:307-308.
4. Capelle HH, Blahak C, Schrader C, Baezner H, Kinfe TM, Herzog J, Dengler R, Krauss JK (2010) Chronic deep brain stimulation in patients with tardive dystonia without a history of major psychosis. Mov Disord 25:1477-1481.
5. Casey DE (1985) Spontaneous and tardive dyskinesias: clinical and laboratory studies. J Clin Psychiatry 46:42-47.
6. Casey DE (2004) Pathophysiology of antipsychotic drug-induced movement disorders. J Clin Psychiatry 65 [Suppl 9]:25-28.
7. Covey DP, Garris PA (2009) Using fast-scan cyclic voltammetry to evaluate striatal dopamine release elicited by subthalamic nucleus stimulation. Conf Proc IEEE Eng Med Biol Soc 2009:3306-3309.
8. Creed M, Hamani C, Nobrega JN (2011) Deep brain stimulation of the subthalamic or entopeduncular nucleus attenuates vacuous chewing movements in a rodent model of tardive dyskinesia. Eur Neuropsychop harmacol 21:393-400.
9. Creed MC, Hamani C, Nobrega JN (2012) Early gene mapping after deep brain stimulation in a rat model of tardive dyskinesia: comparison with transient local inactivation. Eur Neuropsychopharmacol 22:506-517.
10. Creed-Carson M, Oraha A, Nobrega JN (2011) Effects of 5-HT(2A) and 5-HT(2C) receptor antagonists on acute and chronic dyskinetic effects induced by haloperidol in rats. Behav Brain Res 219:273-279.
11. Damier P, Thobois S, Witjas T, Cuny E, Derost P, Raoul S, Mertens P, Peragut JC, Lemaire JJ, Burbaud P, Nguyen JM, Llorca PM, Rascol O (2007) Bilateral deep brain stimulation of the globus pallidus to treat tardive dyskinesia. Arch Gen Psychiatry 64:170-176.
12. Di Giovanni G, Di Matteo V, Pierucci M, Benigno A, Esposito E (2006) Serotonin involvement in the basal ganglia pathophysiology: could the 5-HT2C receptor be a new target for therapeutic strategies? Curr Med Chem 13:3069-3081.
13. Di Giovanni G, Esposito E, Di Matteo V (2010) Role of serotonin in central dopamine dysfunction. CNS Neurosci Ther 16:179-194.
14. Di Matteo V, Pierucci M, Esposito E, Crescimanno G, Benigno A, Di Giovanni G (2008) Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders. Prog Brain Res 172:423-463.
15. D'Souza DC, Bennett A, Abi-Dargham A, Krystal JH (1994) Precipitation of a psychoneuromotor syndrome by fluoxetine in a haloperidol-treated schizophrenic patient. J Clin Psychopharmacol 14:361-363.
16. Dubovsky SL, Thomas M (1996) Tardive dyskinesia associated with fluox etine. Psychiatr Serv 47:991-993.
17. Feuerstein TJ, Kammerer M, Lucking CH, Moser A (2011) Selective GABA release as a mechanistic basis of high-frequency stimulation used for the treatment of neuropsychiatric diseases. Naunyn Schmiedebergs Arch Pharmacol 384:1-20.
18. Fletcher PJ (1995) Effects of combined or separate 5,7-dihydroxytryptamine lesions of the dorsal and median raphe nuclei on responding maintained by a DRL 20s schedule of food reinforcement. Brain Res 675:45-54.
19. Hamani C, Diwan M, Macedo CE, Brandão ML, Shumake J, Gonzalez-Lima F, Raymond R, Lozano AM, Fletcher PJ, Nobrega JN (2010) Antidepressant-like effects of medial prefrontal cortex deep brain stimulation in rats. Biol Psychiatry 67:117-124.
20. Hamani C, Machado DC, Hipólide DC, Dubiela FP, Suchecki D, Macedo CE, Tescarollo F, Martins U, Covolan L, Nobrega JN (2012) Deep brain stimulation reverses anhedonic-like behavior in a chronic model of depression: role of serotonin and brain derived neurotrophic factor. Biol Psychiatry 71:30-35.
21. Hameleers R, Blokland A, Steinbusch HW, Visser-Vandewalle V, Temel Y (2007) Hypomobility after DOI administration can be reversed by subthalamic nucleus deep brain stimulation. Behav Brain Res 185:65-67.
22. Hartung H, Tan SK, Steinbusch HM, Temel Y, Sharp T (2011) High-frequency stimulation of the subthalamic nucleus inhibits the firing of juxtacellular labelled 5-HT-containing neurones. Neuroscience 186:135-145.
23. Kapur S, Zipursky RB, Remington G (1999) Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Am J Psychiatry 156:286-293.
24. Ketai R (1993) Interaction between fluoxetine and neuroleptics. Am J Psychiatry 150:836-837.
25. Kostrzewa RM, Huang NY, Kostrzewa JP, Nowak P, Brus R (2007) Modeling tardive dyskinesia: predictive 5-HT2C receptor antagonist treatment. Neurotox Res 11:41-50.
26. Lauterbach EC, Shillcutt SD (1997) Dyskinesia with fluoxetine: tardive or late-onset persistent, acute norfluoxetine dyskinesia? J Clin Psychiatry 58:85-86.
27. Lee KH, Blaha CD, Harris BT, Cooper S, Hitti FL, Leiter JC, Roberts DW, Kim U (2006) Dopamine efflux in the rat striatum evoked by electrical stimulation of the subthalamic nucleus: potential mechanism of action in Parkinson's disease. Eur J Neurosci 23:1005-1014.
28. Lyons MK (2011) Deep brain stimulation: current and future clinical applications. Mayo Clin Proc 86:662-672.
29. Meltzer HY, Nash JF (1991) Effects of antipsychotic drugs on serotonin receptors. Pharmacol Rev 43:587-604.
30. Navailles S, De Deurwaerdère P (2012) Contribution of serotonergic transmission to the motor and cognitive effects of high-frequency stimulation of the subthalamic nucleus or levodopa in Parkinson's disease. Mol Neurobiol 45:173-185.
31. Navailles S, Benazzouz A, Bioulac B, Gross C, De Deurwaerdère P (2010) High-frequency stimulation of the subthalamic nucleus and L-3,4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat model of Parkinson's disease. J Neurosci 30:2356-2364.
32. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. New York: Academic.
33. Sandler NH (1996) Tardive dyskinesia associated with fluoxetine. J Clin Psychiatry 57:91
34. Schulte T, Brecht S, Herdegen T, Illert M, Mehdorn HM, Hamel W (2006) Induction of immediate early gene expression by high-frequency stimulation of the subthalamic nucleus in rats. Neuroscience 138:1377-1385.
35. Sgambato-Faure V, Cenci MA (2012) Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease. Prog Neurobiol 96:69-86.
36. Stahl SM (1999) Introduction: what makes an antipsychotic atypical? J Clin Psychiatry 60 [Suppl 10]:3-4.
37. Su PC, Ma Y, Fukuda M, Mentis MJ, Tseng HM, Yen RF, Liu HM, Moeller JR, Eidelberg D (2001) Metabolic changes following subthalamotomy for advanced Parkinson's disease. Ann Neurol 50:514-520.
38. Sun B, Chen S, Zhan S, Le W, Krahl SE (2007) Subthalamic nucleus stimulation for primary dystonia and tardive dystonia. Acta Neurochir Suppl 97:207-214.
39. Tan SK, Hartung H, Sharp T, Temel Y (2011) Serotonin-dependent depression in Parkinson's disease: a role for the subthalamic nucleus? Neuro-pharmacology 61:387-399.
40. Temel Y, Boothman LJ, Blokland A, Magill PJ, Steinbusch HW, VisserVandewalle V, Sharp T (2007) Inhibition of 5-HT neuron activity and induction of depressive-like behavior by high-frequency stimulation of the subthalamic nucleus. Proc Natl Acad Sci U S A 104:17087-17092.
41. Troster AI (2009) Neuropsychology of deep brain stimulation in neurology and psychiatry. Front Biosci 14:1857-1879.
42. Turrone P, Remington G, Nobrega JN (2002) The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D(2) receptor occupancy? Neurosci Biobehav Rev 26:361-380.
43. Turrone P, Remington G, Kapur S, Nobrega JN (2003) Differential effects of within-day continuous vs. transient dopamine D2 receptor occupancy in the development of vacuous chewing movements (VCMs) in rats. Neuropsychopharmacology 28:1433-1439.
44. Wilson JM, Nobrega JN, Carroll ME, Niznik HB, Shannak K, Lac ST, Pristupa ZB, Dixon LM, Kish SJ (1994) Heterogeneous subregional binding patterns of 3H-WIN 35,428 and 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration. J Neurosci 14:2966-2979.
45. Zhang JG, Zhang K, Wang ZC, Ge M, Ma Y (2006) Deep brain stimulation in the treatment of secondary dystonia. Chin Med J 119:2069-2074.